Analysts have modestly raised their fair value estimate for Alm. Brand from DKK 20.00 to DKK 20.50. They cite slight improvements in projected revenue growth and valuation multiples.
What's in the News
- The Danish FSA has approved Alm. Brand A/S' application to expand its Partial Internal Model for solvency capital calculation (Key Developments).
- The expanded model now covers all of Alm. Brand’s insurance activities, including those acquired from Codan in 2022 (Key Developments).
- The regulatory approval is expected to reduce Alm. Brand A/S' solvency capital requirement by approximately DKK 0.6 billion (Key Developments).
- This reduction aligns with the company’s earlier guidance of a DKK 0.5 billion decrease, which was previously announced in May 2025 (Key Developments).
Valuation Changes
- Fair Value Estimate has risen slightly from DKK 20.00 to DKK 20.50.
- Discount Rate remains unchanged at 4.918%.
- Revenue Growth projection has improved modestly, moving from -1.21% to -1.07%.
- Net Profit Margin forecast is nearly unchanged, at 11.32% compared to the previous 11.32%.
- Future P/E Ratio has increased slightly from 19.02x to 19.49x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.